Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 28, 2021JAMA OncologyOpen Access

An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJ. Connor WellsBC Cancer AgencySSShubham SharmaSarojini Naidu Medical CollegeJPJoseph C. Del PaggioThunder Bay Regional Health Sciences Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wells et al. (2021) studied this question.

synapsesocial.com/papers/6a1a5aa7e916fa6dd3b879efhttps://doi.org/10.1001/jamaoncol.2020.7478
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolution of the Randomized Controlled Trial in Oncology Over Three Decades2008 · 161 citations
  2. 2Shifting Patterns in the Interpretation of Phase III Clinical Trial Outcomes in Advanced Non–Small-Cell Lung Cancer: The Bar Is Dropping2014 · 44 citations
  3. 3Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity2014 · 303 citations
  4. 4Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration2017 · 86 citations
  5. 5Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-132017 · 614 citations